https://www.sciencedaily.com/news/health_medicine/cystic_fibrosis/ Cystic Fibrosis (CF) Research News. Read the latest advances in treatment of cystic fibrosis. en-us Sun, 12 Apr 2026 09:05:14 EDT Sun, 12 Apr 2026 09:05:14 EDT 60 https://www.sciencedaily.com/images/scidaily-logo-rss.png https://www.sciencedaily.com/news/health_medicine/cystic_fibrosis/ For more science news, visit ScienceDaily. https://www.sciencedaily.com/releases/2026/03/260315004403.htm Scientists at MIT have discovered that a little-known protein called intelectin-2 plays a powerful double role in defending the gut. The protein strengthens the mucus layer that lines the gastrointestinal tract while also trapping and disabling harmful bacteria that try to break through. By binding to sugars on both mucus molecules and bacterial surfaces, intelectin-2 forms a protective barrier and can even destroy microbes, including some that resist antibiotics. Mon, 16 Mar 2026 00:05:04 EDT https://www.sciencedaily.com/releases/2026/03/260315004403.htm https://www.sciencedaily.com/releases/2025/11/251110021041.htm Scientists have discovered that most chronic fatigue patients experience dysfunctional breathing, which may worsen their symptoms. The likely culprit is dysautonomia, a disruption in how the body controls blood vessels and muscles. Breathing retraining, yoga, or biofeedback could help restore proper breathing rhythm and ease fatigue. The findings open a promising new path for managing this long-misunderstood illness. Mon, 10 Nov 2025 05:47:39 EST https://www.sciencedaily.com/releases/2025/11/251110021041.htm https://www.sciencedaily.com/releases/2025/10/251025084545.htm Scientists at The University of Texas at Austin have developed a revolutionary gene-editing method using bacterial retrons that can correct multiple disease-causing mutations at once. Unlike traditional tools limited to one or two mutations, this retron-based system replaces large defective DNA regions, dramatically improving efficiency and inclusivity for patients with complex disorders like cystic fibrosis. Sat, 25 Oct 2025 10:03:53 EDT https://www.sciencedaily.com/releases/2025/10/251025084545.htm https://www.sciencedaily.com/releases/2025/07/250703230641.htm Stanford researchers discovered that dialing down an overactive enzyme, LRRK2, can regrow lost cellular “antennae” in key brain cells, restoring vital dopamine communication and neuroprotective signals in a mouse model of genetic Parkinson’s. After three months on the LRRK2-blocking drug MLi-2, damaged circuits revived and early signs of neuronal recovery emerged, hinting that timely treatment could not only halt but reverse disease progression—and perhaps benefit other Parkinson’s forms. Thu, 03 Jul 2025 23:44:37 EDT https://www.sciencedaily.com/releases/2025/07/250703230641.htm https://www.sciencedaily.com/releases/2025/03/250325114915.htm Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting the expression or function of Piezo2, a receptor that senses mechanical forces in tissues including stress, strain, and stiffness. The new study sheds light on the underlying mechanisms of pulmonary fibrotic diseases and identifies potential new targets and options for therapy to improve patients' outcomes. Tue, 25 Mar 2025 11:49:15 EDT https://www.sciencedaily.com/releases/2025/03/250325114915.htm https://www.sciencedaily.com/releases/2025/03/250317163744.htm In a recent, cross-institutional study partially funded by the National Institutes of Health, researchers report that healthy human airways are at higher risk for dehydration and inflammation when exposed to dry air, an occurrence expected to increase due to global warming. Inflammation in human airways is associated with such conditions as asthma, allergic rhinitis and chronic cough. Mon, 17 Mar 2025 16:37:44 EDT https://www.sciencedaily.com/releases/2025/03/250317163744.htm https://www.sciencedaily.com/releases/2025/03/250313151952.htm Protein clustering mechanism on the cell membrane presents a new therapeutic target for cystic fibrosis. Thu, 13 Mar 2025 15:19:52 EDT https://www.sciencedaily.com/releases/2025/03/250313151952.htm https://www.sciencedaily.com/releases/2025/03/250312124140.htm Researchers have studied a new method to deliver antibiotics, specifically gentamicin, directly into the bladder tissue to better treat UTIs. They did this by creating nanogels combined with a special peptide (a small protein) that helps the drug get inside the cells where the bacteria are hiding. The results demonstrate that this approach proved highly effective when tested in animal models with UTIs, eliminating over 90% of the bacteria from the bladder. Wed, 12 Mar 2025 12:41:40 EDT https://www.sciencedaily.com/releases/2025/03/250312124140.htm https://www.sciencedaily.com/releases/2025/02/250219225212.htm A discovery offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists have pinpointed proteins in immune cells that, when blocked, could significantly reduce lung tissue scarring. Wed, 19 Feb 2025 22:52:12 EST https://www.sciencedaily.com/releases/2025/02/250219225212.htm https://www.sciencedaily.com/releases/2025/02/250206152318.htm Despite new medication, cystic fibrosis often leads to permanent lung damage. Researchers have discovered that the disease causes changes in the immune system early in life, presumably even in newborns. These changes lead to frequent inflammation and are not affected by drugs targeting the altered mucus production. Thu, 06 Feb 2025 15:23:18 EST https://www.sciencedaily.com/releases/2025/02/250206152318.htm https://www.sciencedaily.com/releases/2024/11/241119132841.htm Scientists discovered a brain circuit that allows us to regulate voluntary breathing, which connects the brain's emotional and behavioral cortical area to its automatic breathing brainstem area. The findings provide a targetable area for slowing breathing in people with anxiety, panic disorders, or PTSD, in addition to explaining the efficacy of slowed, intentional breathing in mindfulness practices like yoga. Tue, 19 Nov 2024 13:28:41 EST https://www.sciencedaily.com/releases/2024/11/241119132841.htm https://www.sciencedaily.com/releases/2024/11/241107193213.htm Mechanical engineers have developed a system of artificial cilia capable of monitoring mucus conditions in human airways to better detect infection, airway obstruction, or the severity of diseases like Cystic Fibrosis (CF), Chronic Obstructive Pulmonary Diseases (COPD) and lung cancer. Thu, 07 Nov 2024 19:32:13 EST https://www.sciencedaily.com/releases/2024/11/241107193213.htm https://www.sciencedaily.com/releases/2024/10/241025122645.htm A new study reveals that the notorious bacterial pathogen Pseudomonas aeruginosa must balance between effectively colonizing human airways and developing antibiotic tolerance to survive. Fri, 25 Oct 2024 12:26:45 EDT https://www.sciencedaily.com/releases/2024/10/241025122645.htm https://www.sciencedaily.com/releases/2024/10/241024145501.htm Researchers discovered potentially far-reaching effects of a particular gut bacterium that was linked to better growth in Bangladeshi children receiving a therapeutic food designed to nurture healthy gut microbes. A strain of the bacterium harbored in the children's gut microbial communities possessed a previously unknown gene capable of producing and metabolizing key molecules involved in regulating many important functions ranging from appetite, immune responses, neuronal function, and the ability of pathogenic bacteria to produce disease. Thu, 24 Oct 2024 14:55:01 EDT https://www.sciencedaily.com/releases/2024/10/241024145501.htm https://www.sciencedaily.com/releases/2024/09/240917125404.htm A study reveals advances in the understanding and treatment of liver fibrosis, a serious complication in the context of metabolic fatty liver disease, also known as MASLD (metabolic dysfunction-associated steatotic liver disease). This study concludes that activation of the PPAR / -AMPK pathway is an effective strategy to slow the development of liver fibrosis. Tue, 17 Sep 2024 12:54:04 EDT https://www.sciencedaily.com/releases/2024/09/240917125404.htm https://www.sciencedaily.com/releases/2024/09/240912135846.htm Researchers have found that a history of repeated antibiotic use causes defects in the normally protective mucus barrier of the gut, due to antibiotic-driven alterations in the microbiota. In a further study, the researchers found a bacteria-independent mechanism through which antibiotics can damage the mucus barrier directly. Thu, 12 Sep 2024 13:58:46 EDT https://www.sciencedaily.com/releases/2024/09/240912135846.htm https://www.sciencedaily.com/releases/2024/08/240829132457.htm Researchers resent a new molecule for visualizing the sphingomyelin metabolism. This offers prospects for innovative therapeutic approaches in infection research. Thu, 29 Aug 2024 13:24:57 EDT https://www.sciencedaily.com/releases/2024/08/240829132457.htm https://www.sciencedaily.com/releases/2024/07/240729173426.htm A canine gallbladder disease that involves the accumulation of abnormal mucus similar to that seen in human cystic fibrosis (CF) patients is caused by improper expression of the gene associated with CF in humans. The finding could have implications for human CF patients as well as for animal models of CF. Mon, 29 Jul 2024 17:34:26 EDT https://www.sciencedaily.com/releases/2024/07/240729173426.htm https://www.sciencedaily.com/releases/2024/07/240717120045.htm Snot might not be the first place you'd expect nanobots to be swimming around. But this slimy secretion exists in more places than just your nose and piles of dirty tissues -- it also lines and helps protect the lungs, stomach, intestines and eyes. And now, researchers have demonstrated in mice that their tiny, enzyme-powered 'snot bots' can push through the defensive, sticky layer and potentially deliver drugs more efficiently. Wed, 17 Jul 2024 12:00:45 EDT https://www.sciencedaily.com/releases/2024/07/240717120045.htm https://www.sciencedaily.com/releases/2024/07/240710195329.htm Cystic fibrosis is one of the most common genetic disorders, causing thick mucus build-up in the lungs and other parts of the body, breathing problems, and infection. Now, researchers have developed a gene-editing approach that efficiently corrects the most common mutation that causes cystic fibrosis, found in 85 percent of patients. With further development, it could pave the way for treatments that are administered only once and have fewer side effects. The new method precisely and durably corrects the mutation in human lung cells, restoring cell function to levels similar to that of Trikafta. Wed, 10 Jul 2024 19:53:29 EDT https://www.sciencedaily.com/releases/2024/07/240710195329.htm https://www.sciencedaily.com/releases/2024/07/240710130858.htm Cystic fibrosis is a hereditary disease that so far has been incurable. Those affected have thick, viscous mucus secretions in their lungs, and lung function diminishes steadily over time. Today, triple combination therapy makes it possible to address the root causes of the defect underlying the disease. This form of treatment was recently approved for children in addition to adults. Wed, 10 Jul 2024 13:08:58 EDT https://www.sciencedaily.com/releases/2024/07/240710130858.htm https://www.sciencedaily.com/releases/2024/07/240704201539.htm Pseudomonas aeruginosa -- an environmental bacteria that can cause devastating multidrug-resistant infections, particularly in people with underlying lung conditions -- evolved rapidly and then spread globally over the last 200 years, probably driven by changes in human behavior, a new study has found. Thu, 04 Jul 2024 20:15:39 EDT https://www.sciencedaily.com/releases/2024/07/240704201539.htm https://www.sciencedaily.com/releases/2024/06/240611130322.htm Chronic lung diseases are often accelerated and exacerbated by polymicrobial infections. An international study has identified two types of these so-called dysbioses in cystic fibrosis. They display distinct ecology and are also likely to respond differently to treatment. Tue, 11 Jun 2024 13:03:22 EDT https://www.sciencedaily.com/releases/2024/06/240611130322.htm https://www.sciencedaily.com/releases/2024/06/240603114344.htm Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) that causes inflammation and ulcers (sores) in the digestive tract. Ulcerative colitis affects the innermost lining of the large intestine, also called the colon and rectum. At least 40,000 people are living with IBD in Ireland, and over 5 million globally. Mon, 03 Jun 2024 11:43:44 EDT https://www.sciencedaily.com/releases/2024/06/240603114344.htm https://www.sciencedaily.com/releases/2024/05/240507150048.htm Understanding how mucus changes, and what it changes in response to, can help diagnose illnesses and develop treatments. Researchers develop a system to grow mucus-producing intestinal cells and study the characteristics of the mucus in different conditions. The process involves growing a layer of intestinal cells on a laboratory plate exposed to air. These cells produce a layer of mucus that the researchers can easily access for testing. Using a magnetic wire, they can measure the consistency of the mucus without affecting its properties, and the platform can explore the effects of pathogens and help develop medications to combat them. Tue, 07 May 2024 15:00:48 EDT https://www.sciencedaily.com/releases/2024/05/240507150048.htm https://www.sciencedaily.com/releases/2024/04/240412125425.htm A recent study uncovers a pathway used during normal wound healing that has the potential to reverse IPF. Fri, 12 Apr 2024 12:54:25 EDT https://www.sciencedaily.com/releases/2024/04/240412125425.htm https://www.sciencedaily.com/releases/2024/04/240411130152.htm A Cystic Fibrosis drug targeting the basic defect that causes the condition has been shown to be safe and effective in newborns aged four weeks and above, new research suggests. Thu, 11 Apr 2024 13:01:52 EDT https://www.sciencedaily.com/releases/2024/04/240411130152.htm https://www.sciencedaily.com/releases/2024/04/240404190719.htm Scientists have discovered a new cause for asthma that sparks hope for treatment that could prevent the life-threatening disease. Thu, 04 Apr 2024 19:07:19 EDT https://www.sciencedaily.com/releases/2024/04/240404190719.htm https://www.sciencedaily.com/releases/2024/03/240313135626.htm Findings from a new study reflect the important role that the gut microbiome (communities of bacteria) plays in the airway health of persons with cystic fibrosis. Wed, 13 Mar 2024 13:56:26 EDT https://www.sciencedaily.com/releases/2024/03/240313135626.htm https://www.sciencedaily.com/releases/2024/03/240305134330.htm Researchers who work with tiny drug carriers known as lipid nanoparticles have developed a new type of material capable of reaching the lungs and the eyes, an important step toward genetic therapy for hereditary conditions like cystic fibrosis and inherited vision loss. Tue, 05 Mar 2024 13:43:30 EST https://www.sciencedaily.com/releases/2024/03/240305134330.htm https://www.sciencedaily.com/releases/2024/02/240228115328.htm Our bodies depend on mucus to function properly. As it turns out, so do some cancer cells. Scientists discovered mucus not only allows young pancreatic cancer cells to grow, but also prevents them from transforming into deadlier, drug-resistant variants. Their discovery exposes a new vulnerability that may point toward future therapeutic strategies. Wed, 28 Feb 2024 11:53:28 EST https://www.sciencedaily.com/releases/2024/02/240228115328.htm https://www.sciencedaily.com/releases/2024/02/240221213859.htm About a decade ago, researchers began to observe a recurring challenge in their research: Some of the compounds they were developing to harness energy from bacteria were instead killing the microbes. Not good if the objective of the project was to harness the metabolism of living bacteria to produce electricity. Wed, 21 Feb 2024 21:38:59 EST https://www.sciencedaily.com/releases/2024/02/240221213859.htm https://www.sciencedaily.com/releases/2024/01/240102142021.htm Higher levels of omega-3, the healthy fat found in fish and nuts, were associated with better lung function and longer transplant-free survival. Tue, 02 Jan 2024 14:20:21 EST https://www.sciencedaily.com/releases/2024/01/240102142021.htm https://www.sciencedaily.com/releases/2023/12/231205170648.htm Sniffles, snorts and blows of runny noses are the hallmarks of cold and flu season -- and that increase in mucus is exactly what bacteria use to mount a coordinated attack on the immune system, according to a new study. The team found that the thicker the mucus, the better the bacteria are able to swarm. The findings could have implications for treatments that reduce the ability of bacteria to spread. Tue, 05 Dec 2023 17:06:48 EST https://www.sciencedaily.com/releases/2023/12/231205170648.htm https://www.sciencedaily.com/releases/2023/11/231121175237.htm Scientists have engineered a living material resembling human phlegm, which will help them to better understand how a certain kind of infection develops on the lungs of patients with cystic fibrosis. Tue, 21 Nov 2023 17:52:37 EST https://www.sciencedaily.com/releases/2023/11/231121175237.htm https://www.sciencedaily.com/releases/2023/11/231102135135.htm Antibiotic-resistant bacteria pose a major challenge to healthcare systems worldwide. Due to numerous resistance mechanisms, infections with the pathogen Pseudomonas aeruginosa are particularly feared. Researchers have now discovered antibodies that could lead to a highly potent treatment option of acute and chronic infections with P. aeruginosa. Thu, 02 Nov 2023 13:51:35 EDT https://www.sciencedaily.com/releases/2023/11/231102135135.htm https://www.sciencedaily.com/releases/2023/11/231101134919.htm The human heart, often described as the body's engine, is a remarkable organ that tirelessly beats to keep us alive. At the core of this vital organ, intricate processes occur when it contracts, where thick and thin protein-filaments interact within the sarcomere, the fundamental building block of both skeletal and heart muscle cells. Any alterations in thick filament proteins can have severe consequences for our health, leading to conditions such as hypertrophic cardiomyopathy and various other heart and muscle diseases. Wed, 01 Nov 2023 13:49:19 EDT https://www.sciencedaily.com/releases/2023/11/231101134919.htm https://www.sciencedaily.com/releases/2023/10/231031111529.htm Alarmingly high rates of bacterial resistance to commonly prescribed antibiotics used to treat children and babies has been found in the Asia-Pacific. Tue, 31 Oct 2023 11:15:29 EDT https://www.sciencedaily.com/releases/2023/10/231031111529.htm https://www.sciencedaily.com/releases/2023/10/231017143617.htm Researchers have developed a human in vitro model that closely mimics the complexities of radiation-induced lung injury (RILI) and radiation dose sensitivity of the human lung. Using a previously developed microfluidic human Lung Alveolus Chip lined by human lung alveolar epithelial cells interfaced with lung capillary cells to recreate the alveolar-capillary interface in vitro, the researchers recapitulated many of the hallmarks of RILI, including radiation-induced DNA damage in lung tissue, cell-specific changes in gene expression, inflammation, and injury to both the lung epithelial cells and blood vessel-lining endothelial cells. By also evaluating the potential of two drugs to suppress the effects of acute RILI, the researchers demonstrated their model's capabilities as an advanced, human-relevant, preclinical, drug discovery platform. Tue, 17 Oct 2023 14:36:17 EDT https://www.sciencedaily.com/releases/2023/10/231017143617.htm https://www.sciencedaily.com/releases/2023/10/231010133528.htm Synthetic anion binders could one day help treat the chronic lung disease. Tue, 10 Oct 2023 13:35:28 EDT https://www.sciencedaily.com/releases/2023/10/231010133528.htm https://www.sciencedaily.com/releases/2023/09/230927154505.htm Experts in cloning and stem cell science are reporting that five lung stem cell variants dominate the lungs of patients with advanced cystic fibrosis, and that these variants drive key aspects of CF pathology including inflammation, fibrosis and mucin secretion. Wed, 27 Sep 2023 15:45:05 EDT https://www.sciencedaily.com/releases/2023/09/230927154505.htm https://www.sciencedaily.com/releases/2023/09/230927002955.htm Lung fibrosis is a debilitating disease affecting nearly 250,000 people in the U.S. alone with 50,000 new cases reported each year. There is currently no cure and limited available treatment options, underscoring the pressing need to better understand why people get this disease. In a new study, Boston University Chobanian & Avedisian School of Medicine researchers have identified that abnormal interactions between different cell types, particularly platelets and lung immune cells, promote lung fibrosis. According to the researchers, this study highlights how different cell types work together in lung fibrosis. Platelets are cells that normally form blood clots, but in lung fibrosis they become involved in immune cell functions that end up attacking healthy cells and damaging the lung. While the immune system is supposed to protect us from viruses and bacteria, in patients with lung fibrosis it harms their own body. Wed, 27 Sep 2023 00:29:55 EDT https://www.sciencedaily.com/releases/2023/09/230927002955.htm https://www.sciencedaily.com/releases/2023/08/230825122019.htm High levels of some minerals and metals in environmental water supplies may increase the risk of nontuberculous mycobacteria (NTM) pulmonary infections in people with cystic fibrosis, according to a new study. The study found the presence of the metals molybdenum and vanadium along with sulfate -- a collection of mineral salts -- in the U.S. municipal water system was associated with an increased incidence of NTM pulmonary infections, the leading cause of drinking-water associated illnesses. Fri, 25 Aug 2023 12:20:19 EDT https://www.sciencedaily.com/releases/2023/08/230825122019.htm https://www.sciencedaily.com/releases/2023/08/230811115519.htm Yoga and breathing control practices, in combination with aerobic training, are particularly key exercises for asthmatic people seeking to improve their lung function, a new peer-reviewed study suggests. Fri, 11 Aug 2023 11:55:19 EDT https://www.sciencedaily.com/releases/2023/08/230811115519.htm https://www.sciencedaily.com/releases/2023/08/230810110016.htm A team of global experts have spent a decade creating a guide to clinical assessments which help inform exercise training for people living with cystic fibrosis. Thu, 10 Aug 2023 11:00:16 EDT https://www.sciencedaily.com/releases/2023/08/230810110016.htm https://www.sciencedaily.com/releases/2023/07/230707111622.htm The mucus in the airways is not as sticky, inflammation in the lungs significantly reduced: Triple combination therapy can achieve these positive, lasting effects in patients with cystic fibrosis (CF). According to new research, this form of medication improves the symptoms of CF in many patients. Fri, 07 Jul 2023 11:16:22 EDT https://www.sciencedaily.com/releases/2023/07/230707111622.htm https://www.sciencedaily.com/releases/2023/05/230522131317.htm Using a new strategy, researchers were able to reduce the challenging MRSA infection in the wounds of diabetic mice by 94%. They were able to completely sterilize the wounds in several of the mice, and the rest had significantly reduced bacterial burden. Mon, 22 May 2023 13:13:17 EDT https://www.sciencedaily.com/releases/2023/05/230522131317.htm https://www.sciencedaily.com/releases/2023/03/230331120636.htm A new type of nanoparticle can be administered to the lungs, where it can deliver messenger RNA encoding useful proteins. Researchers hope to use them to develop new treatments for cystic fibrosis and other lung diseases. Fri, 31 Mar 2023 12:06:36 EDT https://www.sciencedaily.com/releases/2023/03/230331120636.htm https://www.sciencedaily.com/releases/2023/03/230322190931.htm The cystic fibrosis transmembrane conductance regulator has been studied for years but the new efforts have yielded important insights. Wed, 22 Mar 2023 19:09:31 EDT https://www.sciencedaily.com/releases/2023/03/230322190931.htm https://www.sciencedaily.com/releases/2022/12/221222101017.htm Pathogens such as SARS-CoV-2 and pneumococcus can cause severe pneumonia. If the airways then fill with fluid, the patient risks developing acute respiratory distress syndrome. Researchers have now discovered the molecular mechanisms that trigger fluid accumulation in the lungs. This also led them to discover a potential new therapy: A cystic fibrosis drug proved effective in their laboratory experiments, raising hope that this could be used to treat pneumonia regardless of the pathogen that caused it. Thu, 22 Dec 2022 10:10:17 EST https://www.sciencedaily.com/releases/2022/12/221222101017.htm https://www.sciencedaily.com/releases/2022/12/221208085747.htm Scientists compared the blood of nearly 300 individuals with type 1 diabetes to healthy controls, they found that a higher level of antibodies against gentamicin was associated with increased risk of progression to type 1 diabetes. G418 and sisomicin, analogs of gentamicin, also showed a similar association. Thu, 08 Dec 2022 08:57:47 EST https://www.sciencedaily.com/releases/2022/12/221208085747.htm https://www.sciencedaily.com/releases/2022/11/221114095312.htm Researchers have developed a simple urine test to measure the severity of the serious disease cystic fibrosis and assess the effect of new treatments. Mon, 14 Nov 2022 09:53:12 EST https://www.sciencedaily.com/releases/2022/11/221114095312.htm https://www.sciencedaily.com/releases/2022/11/221108120500.htm We breathe to survive. But a breath of fresh air does more than fill our lungs. New research indicates that breathing impacts our emotions, attention and how we can process the outside world. Tue, 08 Nov 2022 12:05:00 EST https://www.sciencedaily.com/releases/2022/11/221108120500.htm https://www.sciencedaily.com/releases/2022/10/221031091351.htm In a new study with obese mice, researchers say they have added to evidence that specialized channel proteins are possible therapeutic targets for sleep apnea and similar abnormally slow breathing disorders in obese people. Mon, 31 Oct 2022 09:13:51 EDT https://www.sciencedaily.com/releases/2022/10/221031091351.htm https://www.sciencedaily.com/releases/2022/10/221026193525.htm Researchers have taken a key step toward improving and lengthening the lives of cystic fibrosis patients, who experience chronically clogged airways and a dramatically shortened life expectancy. Wed, 26 Oct 2022 19:35:25 EDT https://www.sciencedaily.com/releases/2022/10/221026193525.htm https://www.sciencedaily.com/releases/2022/10/221025150224.htm Cystic fibrosis is missed more often in newborn screenings for non-white than white babies, creating higher risk for irreversible lung damage and other serious outcomes in Black, Hispanic, Asian, American Indian and Alaska Native newborns, a new study finds. Tue, 25 Oct 2022 15:02:24 EDT https://www.sciencedaily.com/releases/2022/10/221025150224.htm https://www.sciencedaily.com/releases/2022/10/221018091901.htm A new study has produced a proof of principle for a new 'universal' means of treating COVID-19. Researchers demonstrated in a mouse model that it's possible to prompt the production of a protein that can block multiple variants of the SARS-CoV-2 virus from entering cells and causing respiratory disease. Tue, 18 Oct 2022 09:19:01 EDT https://www.sciencedaily.com/releases/2022/10/221018091901.htm https://www.sciencedaily.com/releases/2022/10/221014135619.htm The classic view of pain is that it protects by detecting and signaling the presence of harmful agents, but new research shows pain can shield the gut more directly. Fri, 14 Oct 2022 13:56:19 EDT https://www.sciencedaily.com/releases/2022/10/221014135619.htm https://www.sciencedaily.com/releases/2022/09/220929133437.htm Cystic fibrosis patients who supplement their diet with vitamin C can also derive greater benefit from another antioxidant, vitamin E, resulting in a reduction in damaging inflammation, a study suggests. Thu, 29 Sep 2022 13:34:37 EDT https://www.sciencedaily.com/releases/2022/09/220929133437.htm https://www.sciencedaily.com/releases/2022/09/220929133354.htm A new drug capsule can help large proteins such as insulin and small-molecule drugs be absorbed in the digestive tract. The capsule has a robotic cap that spins and tunnels through the mucus barrier when it reaches the small intestine, allowing drugs carried by the capsule to pass into cells lining the intestine. Thu, 29 Sep 2022 13:33:54 EDT https://www.sciencedaily.com/releases/2022/09/220929133354.htm